Das US-Thrombektomiegeschäft verzeichnete im 4. Quartal mit einem Anstieg von 27,3 % im Vergleich zum Vorjahr ein deutliches Wachstum.…
Penumbra (PEN) hat sich als Medizintechnikunternehmen auf die minimalinvasive Behandlung von neurovaskulären und peripheren Gefäßerkrankungen spezialisiert. Der US-Markt ist für…
…
Penumbra reports better-than-expected earnings and revenues in the fourth quarter of 2024.…
The headline numbers for Penumbra (PEN) give insight into how the company performed in the quarter ended December 2024, but…
Penumbra (PEN) saw its shares surge in the last session with trading volume being higher than average. The latest trend…
Penumbra stock rises following Strykers Inari Medical acquisition…
PEN stays on investors radars due to its robust portfolio expansion and international growth plans.…
…
The third-quarter results reflect another strong performance by Penumbras U.S. thrombectomy business.…
The latest news from the lab, plus an analysts bullish move, combined to put some zip in the companys shares.…
The company might just be the right kind of business operating at the right time in history.…
Penumbra receives the CE Mark approval for Lightning Flash 2.0 and Lightning Bolt 7 in Europe.…
…
Penumbra (PEN) saw its shares surge in the last session with trading volume being higher than average. The latest trend…
Penumbras (PEN) Thrombectomy product category shows encouraging growth trends, reflecting strong momentum in CAVT products.…
Penumbras (PEN) latest offering is likely to enable physicians to restore blood flow more quickly and further minimize blood loss.…
Penumbra (PEN) expects to materially increase both revenues and profitability in the companys international business in the next three years…
Penumbras (PEN) Q4 revenues register year-over-year growth driven by robust U.S. thrombectomy sales.…
…
Penumbras (PEN) Vascular business is demonstrating strong growth, banking on a rapid increase in sales of vascular thrombectomy products in…
Stocks like DexCom Inc. (DXCM), Integer Holdings (ITGR), Penumbra (PEN), Haemonetics (HAE), Health Equity (HAE) and are likely to continue…
Investors are optimistic about Penumbra (PEN), driven by growth in the vascular segments and upbeat guidance.…
Investors are optimistic about Penumbra (PEN), which is led by growth in vascular and neuro businesses.…
Penumbra (PEN) achieves an important milestone by enrolling the first patient in STORM-PE RCT.…
Penumbra (PEN) expects to materially increase both revenues and profitability of the international business in the next three years and…
Investors are optimistic about Penumbra (PEN) on strong vascular and neuro businesses growth and upbeat guidance.…
…
Penumbras (PEN) vascular and neuro product categories continue to show encouraging growth trends.…
Penumbra (PEN) will likely report strong Neuro sales growth on the strength of its RED 72 (with the proprietary SENDit…
Belluscura has received an 89.6p ($1.09, GBP/USD: 1.2164) midpoint valuation from Stonegate Capital in a research note issued last week.…
Consegic Business Intelligence analyzes that the microcatheter market is growing with a healthy CAGR of 5.1% during the forecast period…
Elsesser, Adam - Vorstand - Tag der Transaktion: 2023-08-11...…
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Penumbras (PEN) U.S. thrombectomy records 50% year-over-year growth, while the international Vascular business sees relatively flat sales in the second…
Penumbra (PEN) delivered earnings and revenue surprises of 53.57% and 3.28%, respectively, for the quarter ended June 2023. Do the…
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
ALAMEDA, Calif., Aug. 1, 2023 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN), a global healthcare company focused on innovative therapies, today…
Alcon, Hologic and Penumbra have been highlighted in this Industry Outlook article....…
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Elsesser, Adam - Vorstand - Tag der Transaktion: 2023-07-11...…
Penumbras (PEN) ability to improve net gross margins and EPS amid ongoing inflationary pressure and supply-chain headwinds buoy optimism....…
Sarna, Surbhi - Aufsichtsrat - Tag der Transaktion: 2023-07-03...…
Roberts, Johanna - Vorstand - Tag der Transaktion: 2023-07-03...…
ALAMEDA, Calif., July 5, 2023 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that it will host a conference call…
Penumbra, Trip.com, Transportadora de Gas del Sur and Vipshop have been highlighted in this Screen of The Week article....…